Clin2
NCT05359848Possibly a fitRecruiting

Intermittent fasting and plant-based eating during chemotherapy

Medical OncologyIntegrative OncologyMedical Nutrition Therapy

Part of Cancer, Hormones & metabolism clinical trials.

This pilot study tests whether alternating periods of lower calorie intake, along with a plant-based diet, is safe and feasible for people receiving chemotherapy. If it helps, it could support better comfort and treatment tolerance during cancer therapy.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are age 18 or older and have confirmed cancer that will be treated with chemotherapy
  • You expect to live at least 6 months
  • Your recent blood tests show your counts and organs are strong enough for chemotherapy (white blood cells, neutrophils, platelets, hemoglobin)
  • Your kidney and liver blood tests are within allowed ranges (creatinine and bilirubin, AST/ALT)
  • You can do usual daily activities fairly well (ECOG 0–1); ECOG 2 or higher is not allowed
  • No serious infection or fever in the week before starting, and you can follow the diet/plan

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05356182Recruiting
Low-protein meals during immunotherapy for cancer patients

This trial tests whether eating low-protein meals helps people with metastatic cancer feel better or tolerate immunotherapy (immune checkpoint inhibitors). It’s mainly a pilot/feasibility study, meaning the goal is to see if the diet is safe and doable during treatment.

Buffalo, New York
NCT06172283Recruiting
Intermittent fasting with hormone therapy for prostate cancer

This trial tests whether intermittent fasting (alternating between eating and not eating for certain periods) can help men with prostate cancer who are receiving hormone therapy (androgen deprivation therapy). It aims to see if fasting during treatment can reduce side effects or improve how well the therapy works.

Buffalo, New York
NCT06645093Recruiting
Intermittent fasting during chemo for lymphoma

This study tests whether intermittent fasting is safe and doable for people with lymphoma who are getting standard chemotherapy (R-CHOP or ABVD). It aims to see if adding fasting periods can help reduce side effects.

Oslo, Oslo
NCT07645742Not yet recruiting
Intermittent fasting with immunotherapy for advanced cancers

This trial studies whether intermittent fasting (eating only during certain hours) can make immunotherapy treatment work better or cause fewer side effects in people with certain advanced cancers. If you can safely fast, this could be a way to boost your treatment.

NCT05990426Recruiting
Alternate day fasting during chemo for gynecologic cancers

This trial tests whether alternating between a fasting day and a normal eating day can help people recovering from gynecologic cancer surgery while they receive chemotherapy. It aims to see if this eating pattern is safe and helpful during treatment.

Chicago, Illinois
NCT05921149Not yet recruiting
Fasting-mimicking diet with chemotherapy for advanced ovarian cancer

This trial tests whether a special low-calorie diet, called a fasting-mimicking diet, can make chemotherapy work better for advanced ovarian cancer. The diet is designed to mimic the effects of fasting while still providing some nutrition, and may help reduce side effects or improve treatment response.

Evanston, Illinois

Hear when a new Medical Oncology trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.